Development of glycosylated nanoparticles for the treatment of urinary tract infection

dc.contributor.guide	Nayak, Usha Y and Raghu Chandrashekhar, H
dc.coverage.spatial	Pharmaceutics
dc.creator.researcher	Nair, Akhil
dc.date.accessioned	2025-11-21T08:19:42Z
dc.date.available	2025-11-21T08:19:42Z
dc.date.awarded	2025
dc.date.completed	2025
dc.date.registered	2020
dc.description.abstract	Available newline
dc.description.note	-
dc.format.accompanyingmaterial	None
dc.format.dimensions	-
dc.format.extent	238p.
dc.identifier.researcherid	0009-0005-5689-0721
dc.identifier.uri	http://hdl.handle.net/10603/675383
dc.language	English
dc.publisher.institution	Manipal College of Pharmaceutical Sciences
dc.publisher.place	Manipal
dc.publisher.university	Manipal Academy of Higher Education
dc.relation	-
dc.rights	university
dc.source.university	University
dc.subject.keyword	Antimicrobial Resistance, Mesoporous silica Nanoparticles,
dc.subject.keyword	Beta Cyclodextrin Nanosponges, Cefotaxime sodium,
dc.subject.keyword	Cefpodoxime proxetil, Green chemistry,
dc.subject.keyword	Urinary Tract Infection, Gram negative infection
dc.title	Development of glycosylated nanoparticles for the treatment of urinary tract infection
dc.title.alternative	-
dc.type.degree	Ph.D.